Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Drug Development
565 Articles Available
1
24
Can't find what you're looking for? Try our
advanced search
.
Drug Development
A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways
PAP-Q1-20-CL-011
In Conversation
In Conversation: NantKwest — Harnessing Natural Killer Cells to Treat Cancer
PAP-Q1-20-CL-016
Artificial Intelligence
Facilitating Drug Re-Innovation with Artificial Intelligence
PAP-Q1-20-CL-020
Epigenetic Research
Translating Epigenetic Research into Promising Cancer Therapies
PAP-Q1-20-CL-022
Coronavirus
Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections
PR-M03-20-NI-024
Drug Development
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
PR-M03-20-NI-007
Coronavirus
BioPharma Services Inc. Donates its Clinical Resources and Scientific Expertise in the Pursuit of Coronavirus COVID-19 Vaccine Research
PR-M03-20-NI-006
Coronavirus
Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19
PR-M02-20-NI-037
Coronavirus
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
PR-M02-20-NI-033
Partnership
Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies
PR-M02-20-NI-025
Patent
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Japan
PR-M02-20-NI-021
Priority Review
Novartis Lung Cancer Drug Granted Priority FDA Review
PR-M02-20-NI-010
Vaccine
CEPI and GSK Collaborate to Develop a Vaccine for Coronavirus
PR-M02-20-NI-001
VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration
PR-M01-20-NI-047
Obesity
Kintai Therapeutics Advances Anti-Obesity Agent After Demonstrating Sustained Weight Loss
PR-M01-20-NI-039
Oncology
Dozens of Non-Oncology Drugs Can Kill Cancer Cells
PR-M01-20-NI-031
Cancer Breakthrough
Progress Report on Cancer Breakthroughs 2020 Project Presented by Dr. Soon-Shiong at J.P. Morgan Healthcare Conference
PR-M01-20-NI-026
Cancer Treatment
NantKwest and ImmunityBio Announce Complete Response in Metastatic Pancreatic Cancer Patient
PR-M01-20-NI-020
Drug Development
LYNPARZA® (olaparib) Approved by FDA as First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer
PR-M01-20-NI-003
FDA Approval
Allergan Receives FDA Approval for Migraine Treatment
PR-M01-20-NI-001
Drug Discovery Platform
Cellarity Founded to Identify New Drugs that Target Specific Cellular Behaviors
PAO-M12-19-NI-004
PR-M12-19-NI-018
FDA Grants Orphan Drug Designation to Epidermolysis Bullosa Treatment
Collaboration
AbbVie and Scripps Research Announce Collaboration to Develop a Broad Range of New Therapeutics
PR-M12-19-NI-021
Ophthalmology
Tackling Genetic Eye Diseases with Novel RNA Therapies
PAP-Q4-19-CL-027
1
24
»
